918499-50-0

Basic information

• Product Name: Carbamic acid, N-[3-[[2-(1-hydroxy-1-propylbutyl)phenyl]amino]-1,1-dimethylpropyl]-, 1,1-dimethylethyl ester
• CAS NO: 918499-50-0
• Molecular Formula: C23H40N2O3
• Molecular Weight: 392.582
• Mol File: 918499-50-0.mol

Chemical Properties

• CAS DataBase Reference: Carbamic acid, N-[3-[[2-(1-hydroxy-1-propylbutyl)phenyl]amino]-1,1-dimethylpropyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, N-[3-[[2-(1-hydroxy-1-propylbutyl)phenyl]amino]-1,1-dimethylpropyl]-, 1,1-dimethylethyl ester(918499-50-0)
• EPA Substance Registry System: Carbamic acid, N-[3-[[2-(1-hydroxy-1-propylbutyl)phenyl]amino]-1,1-dimethylpropyl]-, 1,1-dimethylethyl ester(918499-50-0)

Safety Data

• Hazardous Substances Data: 918499-50-0(Hazardous Substances Data)

Upstream product

• 861842-03-7 4-(2-amino-phenyl)-heptan-4-ol 
• 181646-38-8 (1,1-dimethyl-3-oxo-propyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES

The present invention relates to new pharmaceutical combinations which contain in addition to one or more, preferably one compound of general formula 1 wherein the groups R1, R2 and R3 may have the meanings given in the cl

POWDER FORMULATIONS FOR INHALATION CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS

The present invention relates to powder formulations for inhalation containing enantiomerically pure compounds of general Formula (I) wherein the groups R1, R2 and R3 may have the meanings indicated in the claims and in th

ENANTIOMERICALLY PURE BETA AGONISTS, MANUFACTURING AND USE THEREOF

The present invention relates to enantiomerically pure compounds of formula 1 wherein the groups R1, R2, R3, m and Ym? may have the meanings given in the claims and specification, processes for preparing them an

Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient

Disclosed are medicament combinations which contain in addition to one or more, preferably one, compound of general formula 1 wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″,

NEW PHARMACEUTICALLY-ACTIVE COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES

The present invention relates to the use of the compounds of general formula 1 wherein the groups R1, R2 and R3 may have the meanings specified in the claims and in the description, for preparing a pharmaceutical compositi

New long acting beta-2-agonists and their use as medicaments

The present invention relates to compounds of formula 1 wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″, R2′″, V and n may have the meanings given in the claims an

NOVEL LONG-WORKING BETA-2-AGONISTS AND USE THEREOF AS MEDICAMENTS

The invention relates to compounds of formula (1), wherein groups X, Ra, Rb, R1, R1', R2, R2', R2'', R2''', V and n can have the meanings as cited in the claims and in